EAM
REVBW icon

Empery Asset Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Empery Asset Management’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$10K Hold
233,382
– – 0.06% 70
2022
Q2 		$19K Hold
233,382
– – 0.1% 57
2022
Q1 		$30K Sell
233,382
-16,618
-7% -$4.24K 0.14% 58
2021
Q4 		$135K Buy
+250,000
New +$153K 0.28% 35

Other funds holding REVBW

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Empery Asset Management's REVBW Position: Q3 2022 in Review

Empery Asset Management held its Revelation Biosciences Warrant (REVBW) position steady in Q3 2022 at 233,382 shares worth $10K. The position accounts for 0.06% of the portfolio, ranked #70.

Empery Asset Management first reported a position in REVBW in Q4 2021 and has held it in 4 quarters since. The position peaked at $135K in Q4 2021. 12 funds tracked by Wall St. Rank hold REVBW as of Q3 2022.

  • Empery Asset Management held 233,382 shares of Revelation Biosciences Warrant worth $10K as of Q3 2022.
  • Empery Asset Management left its Revelation Biosciences Warrant share count unchanged in Q3 2022.
  • Revelation Biosciences Warrant made up 0.06% of Empery Asset Management's portfolio in Q3 2022, its #70 holding.
  • Empery Asset Management first reported a position in Revelation Biosciences Warrant in Q4 2021 and has held it in 4 quarters since.
  • Empery Asset Management's Revelation Biosciences Warrant position peaked at $135K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.